8-K: Virpax Pharmaceuticals Director Jaydriane Panis Resigns, Citing Compliance Requirements

Jaydriane Panis resigns from Virpax Pharmaceuticals' Board of Directors and associated committees due to compliance requirements with his employer, effective immediately.

Summary

• On February 3, 2025, Jaydriane (Jay) Panis resigned from the Board of Directors of Virpax Pharmaceuticals, Inc.
• His resignation includes his positions on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
• The resignation was effective immediately and was attributed to compliance requirements related to his current employer.
• Mr. Panis stated that his resignation was not due to any disagreement with the Company on any matter relating to its operations, policies, or practices.
• Virpax Pharmaceuticals will begin the process of identifying a qualified independent director to fill the vacancy.

Sentiment

Score: 6

Explanation: The sentiment is neutral. A board member resigned, but the company is taking steps to address the vacancy and there was no disagreement with the company.

Positives

• Mr. Panis's resignation was not due to any disagreement with the Company on any matter relating to its operations, policies, or practices.
• The company is actively seeking a replacement to fill the vacancy on the board.

Negatives

• The resignation of a board member creates a vacancy that needs to be filled.

Risks

• The company faces the risk of potential disruption or delay in decision-making until a new independent director is appointed.
• There is a risk that finding a suitable replacement may take time and resources.

Future Outlook

The company will begin the process of identifying a qualified independent director to fill the resulting vacancy.

Management Comments

• The Company and the Board express their appreciation for Mr. Paniss service and contributions.

Industry Context

Board member resignations are a common occurrence in publicly traded companies. The reasons for resignation can vary, but it is important for companies to have a plan in place to fill vacancies quickly and efficiently to maintain effective corporate governance.

Management Changes

Stakeholder Impact

• Shareholders may experience short-term uncertainty due to the board vacancy.
• Employees may be indirectly affected by changes in board composition.

Next Steps

• Virpax Pharmaceuticals will identify a qualified independent director to fill the vacancy on the Board.

Key Dates